E. F. Lobova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
E. F. Lobova has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- E. A. Gashina
Омский государственный медицинский университет, Минздрава России
8 shared publications - E. P. Schaefer
City Children's Clinical Hospital No. 3, Omsk, Russia
4 shared publications - Larisa V. Puzyreva
Omsk State Medical University
4 shared publications - Yu. B. Belan
Omsk State Medical University
3 shared publications - L. N. Paimanovа
Omsk State Medical University, Omsk, Russia
2 shared publications - N. A. Sabaeva
City Children's Clinical Hospital No. 3, Omsk, Russia
2 shared publications
Latest Publications
- Open Access
- 25 June 2025
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 24 (2) , 34-38
Clinical cases of hemolytic-uremic syndrome in children with E. coli infection
Among other children infectious diseases hemolytic-uremic syndrome (HUS) remains a significant issue since it can lead to death or chronic kidney pathology. The most vulnerable group are children under the age of 5. The progression of HUS triggered by bacterial intestinal infections is more likely to occur as a sporadic disease in the summer-autumn period.Materials and methods. The article describes clinical observations of patients undergoing treatment at the children infectious hospital at the Budgetary Healthcare Institution of Omsk Oblast City Clinical Hospital №1 named after A.N. Kabanov in Omsk. In each case the development of HUS was preceded by symptoms of acute intestinal infections of medium severity. Сlinical and laboratory manifestations matched the classic version of HUS development. When conducting bacteriological research of stool, causative agents of intestinal infections were not identified. Only in two cases etiological agent was identified using PCR.
- 25 June 2025
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 24 (2) , 34-38
Open AccessClinical cases of hemolytic-uremic syndrome in children with E. coli infection
Among other children infectious diseases hemolytic-uremic syndrome (HUS) remains a significant issue since it can lead to death or chronic kidney pathology. The most vulnerable group are children under the age of 5. The progression of HUS triggered by bacterial intestinal infections is more likely to occur as a sporadic disease in the summer-autumn period.Materials and methods. The article describes clinical observations of patients undergoing treatment at the children infectious hospital at the Budgetary Healthcare Institution of Omsk Oblast City Clinical Hospital №1 named after A.N. Kabanov in Omsk. In each case the development of HUS was preceded by symptoms of acute intestinal infections of medium severity. Сlinical and laboratory manifestations matched the classic version of HUS development. When conducting bacteriological research of stool, causative agents of intestinal infections were not identified. Only in two cases etiological agent was identified using PCR.
- 10 June 2025
- Published by Open Systems Publications in Лечащий врач
- No. 6(28)
The importance of antibacterial therapy of whooping cough in children at the outpatient stage of treatment
Background. Whooping cough, a childhood infectious disease that can cause serious and potentially fatal complications, especially in very young children. The main challenge now is early diagnosis of the disease, which will ensure proper treatment and prevent transmission of infection to others. Objective. The purpose of the study was to evaluate the clinical and laboratory manifestations of whooping cough in children of different age groups, taking into account the outpatient prescription of antibacterial drugs. Materials and methods. Clinical cases of whooping cough in patients treated in a children's infectious diseases hospital (n = 114) were analyzed. Inclusion criteria: age from 0 to 17 years, characteristic clinical manifestations of whooping cough, a sample of patients treated on an outpatient basis during the first week of the disease. The average age of the patients was 3.79 ± 4.9 years. Taking into account the age criterion, the patients were divided into 3 groups. Licensed software version Statistica 13 was used. Discriminant analysis was carried out. Results. Before hospitalization in the infectious diseases hospital, the duration of cough in children was 15.4 ± 10.3 days. 63.2% sought outpatient medical care. PCR diagnostics was carried out by the local pediatric service in half of the cases. Treatment with antibacterial drugs was prescribed to 39.5% of patients. In the hospital, patients up to a year had a more severe course, with frequent complications. At the age of up to 3 years, a severe course was observed in 20.0% of patients, and in the group of patients aged 3 years and older – in 5.7% of children. A comparison of changes in the general blood test in children is provided. The results of laboratory examination of patients are described: bacteriological method, PCR diagnostics and results of enzyme immunoassay. The dependence of antibody registration on the duration of the disease in children with whooping cough has been clearly confirmed. The influence of early administration of antibacterial therapy on clinical manifestations and the development of complications in children with whooping cough was revealed. However, the laboratory diagnosis of whooping cough was not affected by outpatient treatment. Conclusion. Early diagnosis and treatment of whooping cough with antibacterial drugs before the paroxysmal stage of the disease can help mitigate the effects and reduce the spread of this highly contagious disease.
- 10 June 2025
- Published by Open Systems Publications in Лечащий врач
- No. 6(28)
The importance of antibacterial therapy of whooping cough in children at the outpatient stage of treatment
Background. Whooping cough, a childhood infectious disease that can cause serious and potentially fatal complications, especially in very young children. The main challenge now is early diagnosis of the disease, which will ensure proper treatment and prevent transmission of infection to others. Objective. The purpose of the study was to evaluate the clinical and laboratory manifestations of whooping cough in children of different age groups, taking into account the outpatient prescription of antibacterial drugs. Materials and methods. Clinical cases of whooping cough in patients treated in a children's infectious diseases hospital (n = 114) were analyzed. Inclusion criteria: age from 0 to 17 years, characteristic clinical manifestations of whooping cough, a sample of patients treated on an outpatient basis during the first week of the disease. The average age of the patients was 3.79 ± 4.9 years. Taking into account the age criterion, the patients were divided into 3 groups. Licensed software version Statistica 13 was used. Discriminant analysis was carried out. Results. Before hospitalization in the infectious diseases hospital, the duration of cough in children was 15.4 ± 10.3 days. 63.2% sought outpatient medical care. PCR diagnostics was carried out by the local pediatric service in half of the cases. Treatment with antibacterial drugs was prescribed to 39.5% of patients. In the hospital, patients up to a year had a more severe course, with frequent complications. At the age of up to 3 years, a severe course was observed in 20.0% of patients, and in the group of patients aged 3 years and older – in 5.7% of children. A comparison of changes in the general blood test in children is provided. The results of laboratory examination of patients are described: bacteriological method, PCR diagnostics and results of enzyme immunoassay. The dependence of antibody registration on the duration of the disease in children with whooping cough has been clearly confirmed. The influence of early administration of antibacterial therapy on clinical manifestations and the development of complications in children with whooping cough was revealed. However, the laboratory diagnosis of whooping cough was not affected by outpatient treatment. Conclusion. Early diagnosis and treatment of whooping cough with antibacterial drugs before the paroxysmal stage of the disease can help mitigate the effects and reduce the spread of this highly contagious disease.
- 1 January 2025
- Published by Dynasty Publishing House in Infekcionnye bolezni
- Vol. 23 (3)
The effectiveness of probiotics in viral gastroenteritis in children: a comparative open-label study
Objective. To evaluate the clinical efficacy and adverse effects of the complex probiotic Acipol® Forte (Lactobacillus rhamnosus GG + Bifidobacterium longum CECT 7894 + zinc citrate) compared to Linex® Forte and Enterol in children aged 5–8 years with acute intestinal infections (AII) of viral etiology. Patients and methods. An open-label, prospective, non-interventional comparative study involving 165 children randomized into 3 groups: group 1 (n = 55): Linex® Forte (Lactobacillus acidophilus LA-5 + Bifidobacterium animalis subsp. lactis BB-12); group 2 (n = 55): Enterol® (Saccharomyces boulardii CNCM I-745); group 3 (n = 55): Acipol® Forte (L. rhamnosus GG + B. longum CECT 7894 + zinc citrate). All patients received standard symptomatic and detoxification therapy. Efficacy was assessed based on primary (dynamics of diarrhea frequency, duration of diarrheal syndrome) and secondary (duration of abdominal pain, flatulence, vomiting, nausea, fever, weakness, loss of appetite) criteria. Statistical processing – nonparametric methods (Mann–Whitney criterion, χ2, Fisher's exact test). Results. Median duration of diarrhea: group 1 – 5 days, group 2 – 3 days, group 3 – 3 days (p < 0.001). By the third day of treatment, diarrhea was completely relieved in 100% of patients in groups 2 and 3, and in only 40% of patients in group 1. Pain syndrome: in group 3, it was relieved by the third day (median 3 days), in group 1 – by the seventh day, in group 2 – it was not completely relieved even by the tenth day. Flatulence: in group 3, it was relieved by day 3, in groups 1 and 2, by days 5–8. No adverse events were reported in any of the groups. Conclusion. Acipol® Forte demonstrated statistically significant superiority in terms of the speed of relief of diarrhea syndrome, elimination of abdominal pain, and flatulence compared to Linex® Forte and Enterol. The high safety and synergism of its components (LGG, B. longum, zinc citrate) justify its use as a first-line drug for viral acute intestinal infections in children, especially in the presence of pain syndrome and the risk of post-infectious functional disorders of the gastrointestinal tract. Key words: acute intestinal infections, probiotics, Lactobacillus rhamnosus GG, Bifidobacterium longum, zinc, children, diarrhea, visceral pain, microbiota, synergism
- 1 January 2025
- Published by Dynasty Publishing House in Infekcionnye bolezni
- Vol. 23 (3)
The effectiveness of probiotics in viral gastroenteritis in children: a comparative open-label study
Objective. To evaluate the clinical efficacy and adverse effects of the complex probiotic Acipol® Forte (Lactobacillus rhamnosus GG + Bifidobacterium longum CECT 7894 + zinc citrate) compared to Linex® Forte and Enterol in children aged 5–8 years with acute intestinal infections (AII) of viral etiology. Patients and methods. An open-label, prospective, non-interventional comparative study involving 165 children randomized into 3 groups: group 1 (n = 55): Linex® Forte (Lactobacillus acidophilus LA-5 + Bifidobacterium animalis subsp. lactis BB-12); group 2 (n = 55): Enterol® (Saccharomyces boulardii CNCM I-745); group 3 (n = 55): Acipol® Forte (L. rhamnosus GG + B. longum CECT 7894 + zinc citrate). All patients received standard symptomatic and detoxification therapy. Efficacy was assessed based on primary (dynamics of diarrhea frequency, duration of diarrheal syndrome) and secondary (duration of abdominal pain, flatulence, vomiting, nausea, fever, weakness, loss of appetite) criteria. Statistical processing – nonparametric methods (Mann–Whitney criterion, χ2, Fisher's exact test). Results. Median duration of diarrhea: group 1 – 5 days, group 2 – 3 days, group 3 – 3 days (p < 0.001). By the third day of treatment, diarrhea was completely relieved in 100% of patients in groups 2 and 3, and in only 40% of patients in group 1. Pain syndrome: in group 3, it was relieved by the third day (median 3 days), in group 1 – by the seventh day, in group 2 – it was not completely relieved even by the tenth day. Flatulence: in group 3, it was relieved by day 3, in groups 1 and 2, by days 5–8. No adverse events were reported in any of the groups. Conclusion. Acipol® Forte demonstrated statistically significant superiority in terms of the speed of relief of diarrhea syndrome, elimination of abdominal pain, and flatulence compared to Linex® Forte and Enterol. The high safety and synergism of its components (LGG, B. longum, zinc citrate) justify its use as a first-line drug for viral acute intestinal infections in children, especially in the presence of pain syndrome and the risk of post-infectious functional disorders of the gastrointestinal tract. Key words: acute intestinal infections, probiotics, Lactobacillus rhamnosus GG, Bifidobacterium longum, zinc, children, diarrhea, visceral pain, microbiota, synergism
- 1 January 2025
- Published by FSBEI HE NSMU MOH Russia in JOURNAL of SIBERIAN MEDICAL SCIENCES
- Vol. 9 (4)
Listeriosis as a cause of antenatal fetal death
Listeria (L.) monocytogenes is a Gram-positive facultative intracellular pathogen that can cause severe infections through consumption of contaminated food. The risk of developing and poor outcomes of listeriosis in pregnant women is higher than in the general population. The course and outcome of the disease are influenced not only by the host’s immune status but also by the genetic variant of L. monocytogenes and an infective dose. This article presents a brief review of the literature on listeriosis in pregnant women and a clinical case of fetal death associated with a full-blown listeriosis infection in a woman in the second trimester of pregnancy. The patient’s clinical manifestations and management are described. Symptoms of L. monocytogenes infection during pregnancy were nonspecific. Laboratory findings confirmed the infectious origin of the obstetric pathology and the severity of the infection.
- 1 January 2025
- Published by FSBEI HE NSMU MOH Russia in JOURNAL of SIBERIAN MEDICAL SCIENCES
- Vol. 9 (4)
Listeriosis as a cause of antenatal fetal death
Listeria (L.) monocytogenes is a Gram-positive facultative intracellular pathogen that can cause severe infections through consumption of contaminated food. The risk of developing and poor outcomes of listeriosis in pregnant women is higher than in the general population. The course and outcome of the disease are influenced not only by the host’s immune status but also by the genetic variant of L. monocytogenes and an infective dose. This article presents a brief review of the literature on listeriosis in pregnant women and a clinical case of fetal death associated with a full-blown listeriosis infection in a woman in the second trimester of pregnancy. The patient’s clinical manifestations and management are described. Symptoms of L. monocytogenes infection during pregnancy were nonspecific. Laboratory findings confirmed the infectious origin of the obstetric pathology and the severity of the infection.
- Open Access
- 16 November 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (4) , 57-62
Cerebral disorders as a complication of whooping cough in a child under one year old
Whooping cough is a widespread infectious disease, the manifestations of which vary from nonspecific cough to life-threatening conditions with the development of apnea, hypoxic damage to the central nervous system, and respiratory failure, especially in young children. Against the background of a severe form of whooping cough, hemorrhages of various types can be observed, including in the brain. The team of authors describes a clinical case of cerebral impairment in a child under one year of age, which is associated with whooping cough. A day after discharge from the infectious diseases hospital, the child developed a generalized convulsive attack. Clinical, instrumental and objective data allowed us to establish a diagnosis: acute disorder of cerebral and spinal circulation of the hemorrhagic type. Subarachnoid hemorrhage. Severe anemia. Convulsive syndrome. Whooping cough. Subsequently, the development of signs of hydrocephalus was observed over time, with the further formation of multiple cysts and hemiatrophy of the right hemisphere of the brain.
- 16 November 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (4) , 57-62
Open AccessCerebral disorders as a complication of whooping cough in a child under one year old
Whooping cough is a widespread infectious disease, the manifestations of which vary from nonspecific cough to life-threatening conditions with the development of apnea, hypoxic damage to the central nervous system, and respiratory failure, especially in young children. Against the background of a severe form of whooping cough, hemorrhages of various types can be observed, including in the brain. The team of authors describes a clinical case of cerebral impairment in a child under one year of age, which is associated with whooping cough. A day after discharge from the infectious diseases hospital, the child developed a generalized convulsive attack. Clinical, instrumental and objective data allowed us to establish a diagnosis: acute disorder of cerebral and spinal circulation of the hemorrhagic type. Subarachnoid hemorrhage. Severe anemia. Convulsive syndrome. Whooping cough. Subsequently, the development of signs of hydrocephalus was observed over time, with the further formation of multiple cysts and hemiatrophy of the right hemisphere of the brain.
- Open Access
- 26 September 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (3) , 69-72
Clinical case of infectious mononucleosis with facial neuropathy
Клинический случай инфекционного мононуклеоза, осложненный невропатией лицевого нерва
- 26 September 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (3) , 69-72
Open AccessClinical case of infectious mononucleosis with facial neuropathy
Клинический случай инфекционного мононуклеоза, осложненный невропатией лицевого нерва
- Open Access
- 5 October 2023
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 22 (3) , 45-49
Heart lesions in children affected by COVID-19
Ongoing research on SARS-CoV-2 showed the ability of a pathogen to affect cardio-vascular system in the form of myocarditis, dysrhythmia, cardiac failure, etc. According to an infectious diseases hospital in Omsk, changes in the heart were recorded in 3.3% of children hospitalized with COVID-19. Authors conducted a retrospective study of 24 children aged 1—17 years 11 months with a new coronavirus infection who recieved treatment in an infectious diseases hospital at the Budgetary Healthcare Institution of Omsk Oblast City Children's Clinical Hospital №3 in Omsk from October 2020 to December 2021. It was found that heart lesions were more often recorded in children over 10 years old, all males. In most patients, cardiac lesions developed in presence of concomitant pathology and were combined with lung damage. Clinical manifestations indicating involvement in the pathological process of the cardiovascular system appeared in addition to respiratory infection. They were mild and nonspecific.
- 5 October 2023
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 22 (3) , 45-49
Open AccessHeart lesions in children affected by COVID-19
Ongoing research on SARS-CoV-2 showed the ability of a pathogen to affect cardio-vascular system in the form of myocarditis, dysrhythmia, cardiac failure, etc. According to an infectious diseases hospital in Omsk, changes in the heart were recorded in 3.3% of children hospitalized with COVID-19. Authors conducted a retrospective study of 24 children aged 1—17 years 11 months with a new coronavirus infection who recieved treatment in an infectious diseases hospital at the Budgetary Healthcare Institution of Omsk Oblast City Children's Clinical Hospital №3 in Omsk from October 2020 to December 2021. It was found that heart lesions were more often recorded in children over 10 years old, all males. In most patients, cardiac lesions developed in presence of concomitant pathology and were combined with lung damage. Clinical manifestations indicating involvement in the pathological process of the cardiovascular system appeared in addition to respiratory infection. They were mild and nonspecific.
- Open Access
- 2 October 2022
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 21 (3) , 52-55
A clinical case of the new coronavirus infection with cardiac involvement in a child
The ongoing pandemic of the new coronavirus infection allows us to discover new information concerning the clinical course of the disease. Despite the rarer registration and mild course of COVID-19 in children, we get new data on more severe manifestations in the form of damage to various organs including cardiovascular system. SARS-CoV-2 can lead to myocarditis development, arrhythmia, heart failure, etc.According to an infectious diseases hospital in Omsk, heart changes were recorded in 5.8% of hospitalized children with COVID-19. The article presents a clinical case of the new coronavirus infection in a child of 15 years old who was on treatment in the infection diseases hospital of Budgetary Healthcare Institution of Omsk Oblast City Children's Clinical Hospital №3 of Omsk. The diagnosis was confirmed by examining nasopharyngeal smears for evidence of RNA SARS-CoV-2 by PCR. The course of infection in this patient is characterized by myocarditis development following medium severity disease without comorbid pathology.
- 2 October 2022
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 21 (3) , 52-55
Open AccessA clinical case of the new coronavirus infection with cardiac involvement in a child
The ongoing pandemic of the new coronavirus infection allows us to discover new information concerning the clinical course of the disease. Despite the rarer registration and mild course of COVID-19 in children, we get new data on more severe manifestations in the form of damage to various organs including cardiovascular system. SARS-CoV-2 can lead to myocarditis development, arrhythmia, heart failure, etc.According to an infectious diseases hospital in Omsk, heart changes were recorded in 5.8% of hospitalized children with COVID-19. The article presents a clinical case of the new coronavirus infection in a child of 15 years old who was on treatment in the infection diseases hospital of Budgetary Healthcare Institution of Omsk Oblast City Children's Clinical Hospital №3 of Omsk. The diagnosis was confirmed by examining nasopharyngeal smears for evidence of RNA SARS-CoV-2 by PCR. The course of infection in this patient is characterized by myocarditis development following medium severity disease without comorbid pathology.
- Open Access
- 8 July 2021
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 20 (2) , 60-63
Clinical case of multisystem inflammatory syndrome development in a child with new coronavirus infection
Objective:The article deals with a clinical case of new coronavirus infection in a 1 5-year-old child who was receiving treatment in an infectious diseases hospital of City Children's Clinical Hospital №3 during the period from 1 0 October to 1 December 2020.Materials and methods. The diagnosis was confirmed through nasal swabs examination for the presence of SARS-CoV-2 RNA using PCR and SARS-CoV-2 IgM detection through ELISA.Results.The main feature of the infection course in the present patient was multisystem inflammatory syndrome development with long-term fever, maculopapular rash and multisystemic lesions including bilateral pneumonia, acute carditis and polyserositis.
- 8 July 2021
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 20 (2) , 60-63
Open AccessClinical case of multisystem inflammatory syndrome development in a child with new coronavirus infection
Objective:The article deals with a clinical case of new coronavirus infection in a 1 5-year-old child who was receiving treatment in an infectious diseases hospital of City Children's Clinical Hospital №3 during the period from 1 0 October to 1 December 2020.Materials and methods. The diagnosis was confirmed through nasal swabs examination for the presence of SARS-CoV-2 RNA using PCR and SARS-CoV-2 IgM detection through ELISA.Results.The main feature of the infection course in the present patient was multisystem inflammatory syndrome development with long-term fever, maculopapular rash and multisystemic lesions including bilateral pneumonia, acute carditis and polyserositis.